Main Subject - Internet and Businesses Online

Recent research by email services firm eROI for Q3 2005 provides the following insights.

Micro mailers (with a list s

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ize under 5,000) had read rates that averaged slightly over 35% and click rates between 5% and 9%. Those results are w

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ell above the broad average of 27% and 4.4%. The weekends were the best time for click-throughs, averaging 8% to 9% ve

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

rsus 5% to 6% for Tuesday through Thursday.

Use this link to download the eROI report.

Some surveys report open rate

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

s (read rates) of close to 80% for niche in-house lists with highly targeted messages.

When looking at this type of d

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ata you need to be careful about its relevance to your business. Often the majority of data relates to Business-to-Con

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

sumer (B2C) lists. These are usually the huge lists with a high frequency of messages.

So if your company is in the B

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

siness-to-Business arena you need to think carefully about the impact for your particular situation. B2B lists are gen

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

erally smaller and less frequent.

My observations of other survey results over the last six months or so tend to agre

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

e with the findings by the eROI study – that the average open rate is around 30%. That means two-thirds of people aren

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

’t even opening your message.

Imagine standing in a room and making an announcement. Also imagine that two-thirds of

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

the group ignore you!

But it may not be that bad.

The ‘open rate’ can be measured in different ways by different sur

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

veys. For example, is the message ‘opened’ when it appears in a preview pane, or just when the full message is display

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ed?

My gut feel is that the overall ‘view’ rate would be slightly higher than the open rate reported by various studi

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

s. But it is still quite low. Probably not even 50%.

So don’t rely on email alone to get your message across.

All se

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

rvice businesses need an integrated marketing strategy to ensure they are consistently reaching clients and prospects.

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

Unlike a product that may sit in front of the customer as a constant reminder of who supplied it, your service might

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

be invisible until next time it is needed.

You have to stay in front of your clients so they don’t forget you.

Emai

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

l is a great tool to use, but don’t put all your marketing eggs in the one basket. Increase the effectiveness – and re

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

liability – of your marketing activities by including the opportunity to create a variety of touch-points with clients

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/47722/mainsubjects-Do-Your-Emails-Get-Read.html">Do Your Emails Get Read</a>

BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/47722/mainsubjects-Do-Your-Emails-Get-Read.html]Do Your Emails Get Read[/url]

Eight types of entrepreneurs organized by their primary motivations based on my working practice with tech entrepreneurs.

There are many coating businesses in the market today, but have you ever asked yourself how one gets into this line of work? How they are formed or what prompts someone or some entrepreneur to go out and start a business to fill this niche? Well this is an interesting case study that shows how we became interested in this industry from a sub market of the coating business; Spray in Bed Liners.

Traditional marketing has died. Find out why. It's been replaced by 21st Century marketing. What's that? This article explains why. Marketing your products and services is a must for business success. The article is most important to your continuing success.

Tags

Links

Main Subject - Do Your Emails Get Read

Related Articles: